Results 121 to 130 of about 24,030 (281)
Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
Diabetes, Metabolic Syndrome and Obesity, 2014 Arianne N Sweeting,1 Eddy Tabet,1 Ian D Caterson,1,2 Tania P Markovic1,2 1Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; 2Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, University of Sydney ...
Sweeting AN +3 more
doaj
Topiramate use in alprazolam addiction
, 2006 Alprazolam is successful in reducing anxiety but has a high addictive/misuse potential. Topiramate is a novel anticonvulsant which has been used as a mood stabilizer.
Douzenis, Athanasios +4 more
core
Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency
Obesity, EarlyView.ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak +2 more
wiley +1 more source
Topiramate induced metabolic acidosis and kidney stones – a case study
, 2017 IntroductionThe aim of this study is to present a case of 44 years old woman with topiramate induced metabolic acidosis and kidney stones. Materials and methodsThe laboratory features of topiramate caused renal tubular acidosis in blood and urine during ...
Andel, Ivan +5 more
core +1 more source
Obesity, EarlyView.ABSTRACT Objective This study aimed to evaluate the association of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) with risks of osteoporosis, major osteoporotic fractures, and degenerative musculoskeletal disorders in nondiabetic adults with obesity compared with other obesity medications.
Jie‐Syuan Wu +5 more
wiley +1 more source
Acute psychotic symptoms induced by topiramate
, 1999 The incidence of psychosis during clinical trials of topiramate was 0.8%, not significantly different from the rate for placebo or reported rates of psychosis in patients with refractory epilepsy.
Faught, Edward +3 more
core +1 more source
A Comprehensive Review of the Genetic Etiology and Management of Orofacial Clefts
Pediatric Discovery, EarlyView.ABSTRACT Cleft lip (CL) and cleft palate (CP), collectively referred to as orofacial clefts (OFCs), are among the most common birth defects and can have significant effects on speech, nutrition, and physical and psychosocial development. Manifestation, classification, and treatment plans of OFCs are diverse and not standardized.
Emily Kim +3 more
wiley +1 more source
Efikasi dan Toleransi Monoterapi Topiramate pada Epilepsi
, 2016 Latar belakang. Epilepsi merupakan masalah besar dalam bidang pediatri, masih terdapat 10%-15% pasien yang resisten terhadap pengobatan. Topiramate sebagai obat antiepilepsi baru mempunyai spektrum luas untuk anti kejang.
Prastiya Indra Gunawan
core +1 more source
PM&R, EarlyView.Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen +7 more
wiley +1 more source
, 1999 The effectiveness and safety of topiramate in 87 children with intractable epilepsy treated at three Canadian Centers were evaluated at the IWK-Grace Health Centre, Halifax, NS ...
J Gordon Millichap
core +1 more source